Beijing’s blocking of the Qualcomm/NXP merger sends a clear signal China is using its power to rule on mergers and acquisitions as a weapon against the US amid escalating trade tensions.
Collapse of its bid for MoneyGram reflects mounting scepticism China's giant data aggregators can secure clients’ privacy. This perception could seriously hinder growth.
Chinese buyers caught in a US regulatory quagmire can take their chances with smaller deals or hope a massive shake-up of Washington's dealings with Beijing brings a little clarity.
Adam Tan, CEO of the Chinese airlines-to-property conglomerate, says a grim regulatory environment and questions over its ownership and finances won't stop dealmaking.
While the US president's decision to block a Chinese-backed buyout of semiconductor firm Lattice surprised no one, it does bode poorly for a host of other purchases.
The vendor of US semiconductor manufacturer plans a direct appeal to President Trump, but Beijing-backed Canyon Bridge Capital is already looking elsewhere for deals.
The Trump administration is beginning to back up its beligerent words with action, and deals in the biotech and semiconductors sectors are at particular risk.
Regulatory woes in Washington, including over China Zhongwang's deal for Aleris, are raising questions over whether Chinese buyers will be put off M&A in the USA